PHARMACOECONOMIC STUDY OF THE INTERRUPTION OF TREATMENT WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA. EXPERIENCE IN REAL CLINICAL PRACTICE

被引：0

作者：

Merchan, Munoz B. ^{[1
]}

Nuevo, Lopez, I ^{[1
]}

De Miguel, Llorente D. ^{[1
]}

Gil, Perez A. ^{[1
]}

Morales, Sanz M. D. ^{[1
]}

Perez, Ortega A. ^{[1
]}

Guillen, Garcia H. ^{[1
]}

Mora, Argumanez M. ^{[1
]}

Vazquez, Ramo A. ^{[1
]}

Santos, Morales A. B. ^{[1
]}

Golbano, Lopez N. ^{[1
]}

Herrero, Martin S. ^{[1
]}

Arbeteta, Juanis J. ^{[1
]}

Subira, D. ^{[1
]}

机构：

[1] Hosp Univ Guadalajara, Dept Hematol, Guadalajara, Spain

来源：

HAEMATOLOGICA | 2020年 / 105卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PO-029

引用

页码：153 / 154

页数：2

共 50 条

[41] Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study
Conte, Cecile
Vayr, Flora
Pajiep, Marie-Christelle
Despas, Fabien
Huguet, Francoise
Mestre, Maryse Lapeyre
Gauthier, Martin
Herin, Fabrice
SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 5431 - 5440
[42] FREE REMISSION OF TREATMENT IN REAL LIFE CHRONIC MYELOID LEUKEMIA. TYROSINE KINASE INHIBITORS TREATMENT SUSPENSION EXPERIENCE IN A CENTER
Carlos Alberto, Davalos Cedillo
Chamorro Pablo, Chamorro
Gomez Laura, Serrano
Canal Cristina, Fernandez
Garcia Esther, Gonzalez
Alvarez Ruben, Fernandez
Marinas Veronica, Robles
Fernandez Beatriz, Ordonez
Gonzalez Almudena, Fernandez
Alvarez Carmen, Fernandez
Faria Dianis, Escorcio
Collazos Paula, Chavez
Varona Juan, Torres
HAEMATOLOGICA, 2021, 106 (10) : 364 - 364
[43] NONADHERENCE AND TREATMENT INTERRUPTION OF TYROSINE KINASE INHIBITORS ASSOCIATION WITH HEALTH CARE RESOURCE COST AND UTILIZATION IN CHRONIC MYELOID LEUKEMIA PATIENTS
Hsieh, K. P.
Chen, L. C.
Lin, C. L.
Yang, Y. H.
VALUE IN HEALTH, 2013, 16 (03) : A143 - A143
[44] Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment
Wieczorek, Agnieszka
Uharek, Lutz
BIOMARKER INSIGHTS, 2015, 10 : 49 - 54
[45] Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia
Szeto, Andy H.
Bucci, Tyler
Deal, Allison
Zhu, Anqi
Ahmad, Majd
Cass, Amanda S.
Sketch, Margaret R.
Kemper, Ryan
Zeidner, Joshua F.
Foster, Matthew C.
Muluneh, Benyam
Crona, Daniel J.
ANNALS OF PHARMACOTHERAPY, 2022, 56 (07) : 753 - 763
[46] RESPONSE TO THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA WITH TYROSINE-KINASE INHIBITORS IN THE AREA 1 OF THE REGION OF MURCIA
Lopez Raul, Perez
Perianes Valentin, Cabanas
Piqueras Mercedes, Berenguer
Fierrez Eduardo, Salido
Candel Faustino, Garcia
Ana Maria, Garcia Hernandez
Juan Jose, Cerezo Manchado
Blanquer Miguel, Blanquer
Maria Jose, Moreno Belmonte
Francesca, Labaddia
Marin Amelia, Martinez
Arnao Maria, Moya
Mitat Alina, Ramon
Amor Antonia, Melero
Francesca, Labbadia
Garcia Consuelo, Gonzalez
Poveda Elena, Fernandez
Jose Maria, Moraleda Jimenez
HAEMATOLOGICA, 2016, 101 : 348 - 348
[47] DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE
Martinez de Pinillos, A.
Nasuti, P.
Anger, C.
Ricote, I
VALUE IN HEALTH, 2018, 21 : S57 - S57
[48] The role of stem cell transplantation in paediatric patients with chronic myeloid leukaemia in the era of tyrosine kinase inhibitors
Suttorp, M.
Tauer, J. T.
von Neuhoff, N.
Nowasz, C.
Bradtke, J.
Teigler-Schlegel, A.
Thiede, C.
BONE MARROW TRANSPLANTATION, 2013, 48 : S52 - S52
[49] New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Kimura, Shinya
Ashihara, Eishi
Maekawa, Taira
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (05) : 371 - 379
[50] Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)
Suttorp, M.
Tauer, J. T.
Jaeger, B. A. S.
Rosen-Wolff, A.
KLINISCHE PADIATRIE, 2011, 223 (01): : 46 - 46

← 1 2 3 4 5 →